Bionovate Technologies(OTC) BIIO

Bionovate Technologies Corp is a medical device company focused on developing automated solutions for the treatment of age spots. The company aims to create a sophisticated, computer-driven system that targets and treats these blemishes effectively across various body areas. Founded in 2010 in Cham, Switzerland, Bionovate Technologies has positioned itself to market its innovative systems globally to healthcare providers and wellness centers.

Products and Services

• Automated systems for age spot treatment
• Advanced technology targeting skin blemishes
• Global distribution to healthcare providers and wellness centers

Growth Outlook

• Plans to expand product distribution internationally
• Focus on innovative technology to capture market share
• Potential partnerships with healthcare providers for broader reach

Financial Highlights

• Recent quarterly net income of -$21,636
• Trailing twelve months (TTM) return on equity at 23.68%
• Current liabilities totaling $524,845 as of September 30, 2021

Bionovate Technologies Corp is positioned in the healthcare sector, specifically within the medical devices industry. The company has a clear focus on innovation, aiming to address a common cosmetic concern with advanced technology. Despite recent financial challenges, including negative net income, the company demonstrates a strong return on equity, indicating effective use of shareholder funds. The current liabilities suggest a need for careful financial management as the company seeks to grow and expand its market presence. Overall, Bionovate Technologies presents an intriguing opportunity for investors interested in the evolving medical device landscape.